Keyphrases
Tolerability
100%
Older Patients
100%
Fesoterodine
100%
Overactive Bladder Symptom Score (OABSS)
100%
Vulnerable People
28%
Literature Search
14%
Clinical Trials
14%
Comorbidity
14%
Older Adults
14%
Functional Impairment
14%
Central Nervous System
14%
Pharmacotherapy
14%
Specific Needs
14%
Central Nervous System Effects
14%
Dose Adjustment
14%
Active Metabolite
14%
Renal Insufficiency
14%
Hepatic Insufficiency
14%
M2 muscarinic Receptor
14%
P-gp Substrate
14%
FORTA
14%
M3 muscarinic Receptor
14%
Flexible Dosing
14%
INIS
patients
100%
safety
100%
adults
100%
bladder
100%
symptoms
25%
central nervous system
25%
doses
12%
liver
12%
risks
12%
receptors
12%
clinical trials
12%
reviews
12%
efficiency
12%
metabolites
12%
kidneys
12%
affinity
12%
classification
12%
adjustments
12%
balances
12%
substrates
12%
pharmacotherapy
12%
Pharmacology, Toxicology and Pharmaceutical Science
Tolerability
100%
Overactive Bladder
100%
Fesoterodine
100%
Clinical Trial
14%
Functional Disease
14%
Active Metabolite
14%
Pharmacotherapy
14%
Lower Urinary Tract Symptom
14%
Moderate Renal Impairment
14%
Moderate Hepatic Impairment
14%
Muscarinic M2 Receptor
14%
Comorbidity
14%